ADTX_OUT_1 [2025-03-19 12:00:05 -0400] 2436 Bytes | 671 tokens | Cum: 671 tkns (8.39% of 8k)
==========================================================================

We are in the 'Lightning Round' baby! It's 12:00:04 PM on Wednesday March 19, 2025 ET (UTC-0400), and I'm firing up the spotlight on Aditxt (ADTX), moving from 7.5 to 11.2301. Is this a can’t-miss rocket or a one-hit wonder? Let’s dissect the numbers!

Here's the first list of news for Aditxt:

C1 - Mar-18-25 07:22AM - Appili Therapeutics Announces Submission of U.S. Federal Government Funding Proposals and Provides Corporate and Aditxt Transaction Update
C2 - Mar-17-25 08:15AM - Aditxt Provides Business Status Overview and Announces Launch of Aditxt Weekly Update Starting Friday, March 21, 2025
C3 - Mar-12-25 04:15PM - Aditxt, Inc. (NASDAQ: ADTX) Announces 1-for-250 Reverse Stock Split Effective at the Open of Trading on March 17, 2025
C4 - Mar-06-25 08:15AM - Aditxt Subsidiary Adimune to Ship Drug Substances for Final Drug Product Formulation of ADI-100 Ahead of Planned Clinical Trials in Type 1 Diabetes and Psoriasis in Germany, and Stiff Person Syndrome at the Mayo Clinic in the U.S.
C5 - Feb-22-25 08:45AM - Aditxt subsidiary Persanta engages Dominary Securities for IPO
C6 - Feb-21-25 08:15AM - Aditxt Subsidiary Pearsanta Engages Dominari Securities for its Initial Public Offering, to Drive U.S. and Global Commercial Launch of Early Cancer Detection and Diagnosis Targeted for H2 2025
C7 - Feb-13-25 08:15AM - Aditxt to Host Fireside Chat on Friday, February 21st at 11:30 AM Eastern Time
C8 - Jan-13-25 08:15AM - Aditxt's Board of Directors Unanimously Approve Positioning Pearsanta for IPO to Support Global Launch of its Early Cancer Detection Platform

ONLY 3 RULES for AI:
==============
1) This is a document retrieval system. You are the analyst-investigator.
2) You can request items from any list to get more details about Aditxt (ADTX)
3) AFTER requesting and reading News and SEC filings you'll get tokens to write a summary, set a score and high price target, and finally take an exit quiz.
Now, your response should be only 2 or 3 chars. You can say ex., C1, C2, etc., or NEX
The NEX command delivers the NEXt list of News/SEC/Metrics
There are several more lists that use our unified document retrieval system in subsequent prompts.

Thank you for your analysis of Aditxt.
Your predictons will be compared to reality to rate your accuracy. Try to predict accurately. GOOD LUCK!

Please request a document, read, summarize and score. Say something like "C1".

ADTX_OUT_3 [2025-03-19 12:00:17 -0400] 426 Bytes | 133 tokens | Cum: 806 tkns (10.08% of 8k)
==========================================================================

Showing C3 (chunk 1 of 1): C3:
**Aditxt, Inc. (NASDAQ: ADTX) Announces 1-for-250 Reverse Stock Split Effective at the Open of Trading on March 17, 2025**
Date: Mar-12-25 04:15PM
Source: (Business Wire)
URL: https://www.businesswire.com/news/home/20250312389566/en/

Error fetching article: 403 Client Error: Forbidden for url: https://www.businesswire.com/news/home/20250312389566/en/

-- More? (MOR) or Next section? (NEX)

ADTX_OUT_5 [2025-03-19 12:00:19 -0400] 984 Bytes | 300 tokens | Cum: 1279 tkns (15.99% of 8k)
==========================================================================

We present this news so you can catch the big movers from recently breaking news.
Here's a list of news articles you can literally read just by asking.
Usually the first item is the most important.

A1 - 2025-03-18T17:30:27Z - S&P 500 Down 1%; Sarepta Therapeutics Shares Plunge - Aditxt (NASDAQ:ADTX), FinVolution Gr (NYSE:FIN...
A2 - 2025-03-18T15:32:08Z - Why Aditxt (ADTX) Stock Is Skyrocketing - Aditxt (NASDAQ:ADTX)...
A3 - 2025-03-18T14:13:05Z - Dow Dips Over 200 Points; US Industrial Production Increases More than Expected - Aditxt (NASDAQ:ADT...
A4 - 2025-03-18T14:02:08Z - Appili Therapeutics Announces Submission of U.S. Federal Government Funding Proposals and Provides C...
A5 - 2025-03-18T11:50:32Z - Appili Therapeutics Provides Update on Going-Private Transaction with Aditxt (ADTX)...

Request an article by its reference number. (Ex., "A1" gets the first item)
You may also say NEX to go to the next listing.
Response to this prompt limited to 3 chars.

ADTX_OUT_7 [2025-03-19 12:00:20 -0400] 967 Bytes | 300 tokens | Cum: 1581 tkns (19.76% of 8k)
==========================================================================

Showing A1 (chunk 1 of 5): A1:
**S&P 500 Down 1%; Sarepta Therapeutics Shares Plunge - Aditxt (NASDAQ:ADTX), FinVolution Gr (NYSE:FINV)**Date: 2025-03-18Source: {'uri': 'benzinga.com', 'dataType': 'news', 'title': 'Benzinga'}URL: https://www.benzinga.com/25/03/44382084/s-sarepta-therapeutics-shares-plungeU.S. stocks traded lower midway through trading, with the S&P 500 falling around 1% on Tuesday.

The Dow traded down 0.81% to 41,504.25 while the NASDAQ dipped 1.44% to 17,551.39. The S&P 500 also fell, dropping, 1.04% to 5,616.32.

Check This Out: Jim Cramer Calls This Stock A 'Meme Stock,' Recommends Buying Accenture

Leading and Lagging Sectors

Materials shares fell by just 0.3% on Tuesday.

In trading on Tuesday, communication services shares dipped by 2.6%.

Top Headline

IHS Holding Limited IHS posted better-than-expected fourth-quarter results.

IHS Holding reported quarterly earnings of 73 cents per share

-- More? (MOR) or Next section? (NEX)

ADTX_OUT_9 [2025-03-19 12:00:22 -0400] 967 Bytes | 240 tokens | Cum: 1823 tkns (22.79% of 8k)
==========================================================================

Showing A1 (chunk 2 of 5): which beat the analyst consensus estimate of 9 cents per share. The company reported quarterly sales of $437.822 million which beat the analyst consensus estimate of $424.001 million.

Equities Trading UP

Aditxt, Inc. ADTX shares shot up 57% to $6.88 after the company announced it submitted an application for four new federal funding opportunities. Shares of Harrow, Inc. HROWgot a boost, surging 16% to $26.96 following fourth-quarter results. FinVolution Group FINV shares were also up, gaining 18% to $10.72 after the company reported better-than-expected fourth-quarter financial results. Also, the company announced a new $150 million share repurchase program.

Equities Trading DOWN

Gyre Therapeutics, Inc GYRE shares dropped 27% to $9.02 following fourth-quarter results. Shares of Sarepta Therapeutics, Inc. SRPT were down 22% to $78.60 after the company reported a patient death followi

-- More? (MOR) or Next section? (NEX)

ADTX_OUT_11 [2025-03-19 12:00:23 -0400] 990 Bytes | 298 tokens | Cum: 2123 tkns (26.54% of 8k)
==========================================================================

This is our final list of news.
News AI can literally read just by asking.
Don't miss the breaking news!

B1 - 2024-11-06T22:55:00Z - Appili Therapeutics Announces Results of Special Meeting of Shareholders
B2 - 2024-10-10T19:40:00Z - Appili Therapeutics – Press Release Correction
B3 - 2024-04-02T17:23:42Z - Why Stryve Foods Shares Are Trading Lower By Around 25%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
B4 - 2024-01-02T18:35:24Z - Why Longboard Pharmaceuticals Shares Are Trading Higher By Around 200%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
B5 - 2024-01-02T13:07:57Z - Why LumiraDx Shares Are Trading Lower By 20%; Here Are 20 Stocks Moving Premarket
B6 - 2023-12-29T18:03:42Z - Why Fisker Shares Are Trading Higher By Over 20%? Here Are Other Stocks Moving In Friday's Mid-Day Session

Request an article by its reference number. (Ex., "B1" gets the first item)
You can say NEX to go to the next listing.
Response limited to 3 chars.

ADTX_OUT_13 [2025-03-19 12:00:30 -0400] 569 Bytes | 147 tokens | Cum: 2272 tkns (28.40% of 8k)
==========================================================================

Showing B1 (chunk 1 of 1): B1:
**Appili Therapeutics Announces Results of Special Meeting of Shareholders**Date: Unknown DateSource: Unknown SourceURL: https://www.globenewswire.com/news-release/2024/11/06/2976211/0/en/Appili-Therapeutics-Announces-Results-of-Special-Meeting-of-Shareholders.htmlAppili Therapeutics Inc. shareholders have overwhelmingly approved a plan of arrangement for Aditxt Inc. to acquire all of Appili's outstanding shares. The transaction is expected to close in Q4 2024, subject to certain conditions.

-- More? (MOR) or Next section? (NEX)

ADTX_OUT_15 [2025-03-19 12:00:32 -0400] 1162 Bytes | 323 tokens | Cum: 2727 tkns (34.09% of 8k)
==========================================================================

This is our list of SEC filings.
Read it just by asking.
Don't miss breaking filings!

S1 - 2025-03-12 8-K Item 7.01 Regulation FD Disclosure

On March 12, 2025, the Company issued a press release announcing the March Reverse Stock Split. A copy of the press release is furnished to this Curr Report on Form 8-K as Exhibit 99.1.

The information in this Item 7.01 and Exhibit 99.1 o...

S2 - 2025-03-12 8-K Item 7.01 Regulation FD Disclosure

On March 12, 2025, the Company issued a press release announcing the March Reverse Stock Split. A copy of the press release is furnished to this Curr Report on Form 8-K as Exhibit 99.1.

The information in this Item 7.01 and Exhibit 99.1 o...

S3 - 2025-03-06 8-K Item 1.01 Entry into a Material Definitive Agrmt

On March 5, 2025, Aditxt, Inc. (the "Company") entered into a Settlement Agrmt (the "Settlement Agrmt") with Aldevron, LLC to resolve certain disputes arising from previously issued invoices under existing services ag...

Request filing by its reference number. (Ex., "S1" gets the first item)
You can say NEX to go to the next listing - but what fun is that?
Response limited to 3 chars.

ADTX_OUT_17 [2025-03-19 12:00:37 -0400] 936 Bytes | 227 tokens | Cum: 2956 tkns (36.95% of 8k)
==========================================================================

Showing S1 (chunk 1 of 1): S1:
Item 7.01 Regulation FD Disclosure

On March 12, 2025, the Company issued a press release announcing the March Reverse Stock Split. A copy of the press release is furnished to this Current Report on Form 8-K as Exhibit 99.1.

The information in this Item 7.01 and Exhibit 99.1 of this Current Report on Form 8-K is furnished and shall not be deemed to be filed for the purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the Exchange Act), or otherwise subject to the liabilities of that section. The information in this Item 7.01 and Exhibit 99.1 of this Current Report on Form 8-K shall not be incorporated by reference into any filing under the Securities Act of 1933, as amended, or the Exchange Act, whether made before or after the date of this Current Report, regardless of any general incorporation language in any such filing....

-- More? (MOR) or Next section? (NEX)

ADTX_OUT_19 [2025-03-19 12:00:50 -0400] 3299 Bytes | 770 tokens | Cum: 3815 tkns (47.69% of 8k)
==========================================================================

This is our set of metrics.
Please analyze the numbers.

+-------------------------+---------------------+-----------------------+-----------------------+---------------------------+-------------------------+
| Prev Close: 7.50 | RSI (14): 37.70 | Perf Quarter: -88.55% | Insider Trans: - | Sales Q/Q: -94.49% | ROE: -16400.32% |
+-------------------------+---------------------+-----------------------+-----------------------+---------------------------+-------------------------+
| Target Price: 610000.00 | ATR (14): 4.66 | Index: - | Option/Short: No / No | Sales past 5Y: 189.52% | ROI: -871.94% |
+-------------------------+---------------------+-----------------------+-----------------------+---------------------------+-------------------------+
| Price: 9.97 | SMA20: -31.50% | Market Cap: 10.27M | Short Float: - | Income: -46.25M | Sales Surprise: 120.59% |
+-------------------------+---------------------+-----------------------+-----------------------+---------------------------+-------------------------+
| Change: 32.88% | SMA50: -58.06% | Shs Outstand: - | Short Ratio: 0.02 | Employees: 47 | EPS Surprise: - |
+-------------------------+---------------------+-----------------------+-----------------------+---------------------------+-------------------------+
| Volume: 37,290,239 | SMA200: -99.80% | Shs Float: - | Short Interest: 0.04M | Debt/Eq: 2.18 | P/E: - |
+-------------------------+---------------------+-----------------------+-----------------------+---------------------------+-------------------------+
| Avg Volume: 1.92M | Perf Week: -29.82% | Inst Own: 24.59% | Beta: 1.26 | Sales Y/Y TTM: -71.70% | Earnings: - |
+-------------------------+---------------------+-----------------------+-----------------------+---------------------------+-------------------------+
| Rel Volume: 51.73 | Perf Month: -63.76% | Insider Own: - | Sales: 0.21M | Profit Margin: -21803.99% | |
+-------------------------+---------------------+-----------------------+-----------------------+---------------------------+-------------------------+

The next section covers any insider trading.
If this section is blank, it's because there've been no recent filings.

Now we've reached the end of the analysis.
You are now allotted tokens to make a final analysis summary.
Please don't use tokens to explain why you didn't have enough information.
Save that for the survey that comes last.

Finish the summary with two scores: MARKET_SCORE[] and PRICE_TARGET[]

If you think there's a 90% likelihood of an upward moves, say: MARKET_SCORE[90]
If you think the high today will be 50% higher, add to the price. Eg., If the price is $5.00, add 50%: PRICE_TARGET[$7.50]
PRICE_TARGET is the highest it is expected to rise today, so it cannot be less than the current price.

After you have completed that, please provide a thought-provoking take, 6-10 words, to use for the headline of this news story.
Like this: AI_RPT_HEADLINE: [6-10 words headline for news story from first summary paragraph]

ADTX_OUT_21 [2025-03-19 12:00:52 -0400] 561 Bytes | 131 tokens | Cum: 4215 tkns (52.69% of 8k)
==========================================================================

Finally, if more data could have improved your confidence which would you have chosen? **Choose one option:**
-> X0 <- Nothing more would have helped my analysis
-> X1 <- More stock-specific news
-> X2 <- More financial metrics
-> X3 <- More SEC filings & insider data
-> X4 <- Broader sector & market news
-> X5 <- General market sentiment & AI confidence levels
-> X6 <- AI's past analysis on similar companies
-> X7 <- AI's past analysis on this exact company
-> X8 <- Something altogether different (explain...)

ADTX_IN_23 [2025-03-19 12:00:53 -0400] 126 Bytes | 29 tokens | Cum: 4251 tkns (53.14% of 8k)
==========================================================================

====================================
[2025-03-19 09:00:53] # Analysis Completed
Elapsed Time: 49.40 seconds